Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.
Honda
Takashi
T
Toyoda
Hidenori
H
Hayashi
Kazuhiko
K
Katano
Yoshiaki
Y
Yano
Motoyoshi
M
Nakano
Isao
I
Yoshioka
Kentaro
K
Goto
Hidemi
H
Yamamoto
Koji
K
Takamatsu
Junki
J
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D001779:Blood Coagulation Factors; D012254:Ribavirin; D007372:Interferons